1 Market Overview
1.1 Sorafenib Introduction
1.2 Market Analysis by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Sorafenib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Sorafenib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 Alnylam Pharmaceuticals
2.3.1 Business Overview
2.3.2 Sorafenib Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 Acceleron Pharma
2.4.1 Business Overview
2.4.2 Sorafenib Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Acceleron Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 Biocon
2.5.1 Business Overview
2.5.2 Sorafenib Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Biocon Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.6 Bionomics
2.6.1 Business Overview
2.6.2 Sorafenib Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bionomics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.7 CASI Pharmaceuticals
2.7.1 Business Overview
2.7.2 Sorafenib Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CASI Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.8 Celgene Corporation
2.8.1 Business Overview
2.8.2 Sorafenib Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corporation Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.9 Enzon Pharmaceuticals
2.9.1 Business Overview
2.9.2 Sorafenib Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Enzon Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.10 Five Prime Therapeutics
2.10.1 Business Overview
2.10.2 Sorafenib Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Five Prime Therapeutics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.11 Fujifilm Kyowa Kirin Biologics
2.11.1 Business Overview
2.11.2 Sorafenib Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Fujifilm Kyowa Kirin Biologics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.12 Genentech
2.12.1 Business Overview
2.12.2 Sorafenib Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Genentech Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.13 Genexine
2.13.1 Business Overview
2.13.2 Sorafenib Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Genexine Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.14 Hetero Drugs
2.14.1 Business Overview
2.14.2 Sorafenib Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Hetero Drugs Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.15 ImClone Systems
2.15.1 Business Overview
2.15.2 Sorafenib Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 ImClone Systems Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.16 Intas Pharmaceuticals
2.16.1 Business Overview
2.16.2 Sorafenib Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Intas Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.17 Levolta Pharmaceuticals
2.17.1 Business Overview
2.17.2 Sorafenib Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Levolta Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.18 Mabtech
2.18.1 Business Overview
2.18.2 Sorafenib Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Mabtech Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Sorafenib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Sorafenib Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Sorafenib Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sorafenib Manufacturer Market Share in 2019
3.3.2 Top 6 Sorafenib Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Sorafenib Market Analysis by Regions
4.1 Global Sorafenib Sales, Revenue and Market Share by Regions
4.1.1 Global Sorafenib Sales and Market Share by Regions (2015-2019)
4.1.2 Global Sorafenib Revenue and Market Share by Regions (2015-2019)
4.2 North America Sorafenib Sales and Growth Rate (2015-2019)
4.3 Europe Sorafenib Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Sorafenib Sales and Growth Rate (2015-2019)
4.5 South America Sorafenib Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Sorafenib Sales and Growth Rate (2015-2019)
5 North America Sorafenib by Country
5.1 North America Sorafenib Sales, Revenue and Market Share by Country
5.1.1 North America Sorafenib Sales and Market Share by Country (2015-2019)
5.1.2 North America Sorafenib Revenue and Market Share by Country (2015-2019)
5.2 United States Sorafenib Sales and Growth Rate (2015-2019)
5.3 Canada Sorafenib Sales and Growth Rate (2015-2019)
5.4 Mexico Sorafenib Sales and Growth Rate (2015-2019)
6 Europe Sorafenib by Country
6.1 Europe Sorafenib Sales, Revenue and Market Share by Country
6.1.1 Europe Sorafenib Sales and Market Share by Country (2015-2019)
6.1.2 Europe Sorafenib Revenue and Market Share by Country (2015-2019)
6.2 Germany Sorafenib Sales and Growth Rate (2015-2019)
6.3 UK Sorafenib Sales and Growth Rate (2015-2019)
6.4 France Sorafenib Sales and Growth Rate (2015-2019)
6.5 Russia Sorafenib Sales and Growth Rate (2015-2019)
6.6 Italy Sorafenib Sales and Growth Rate (2015-2019)
7 Asia-Pacific Sorafenib by Country
7.1 Asia-Pacific Sorafenib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Sorafenib Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Sorafenib Revenue and Market Share by Country (2015-2019)
7.2 China Sorafenib Sales and Growth Rate (2015-2019)
7.3 Japan Sorafenib Sales and Growth Rate (2015-2019)
7.4 Korea Sorafenib Sales and Growth Rate (2015-2019)
7.5 India Sorafenib Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Sorafenib Sales and Growth Rate (2015-2019)
8 South America Sorafenib by Country
8.1 South America Sorafenib Sales, Revenue and Market Share by Country
8.1.1 South America Sorafenib Sales and Market Share by Country (2015-2019)
8.1.2 South America Sorafenib Revenue and Market Share by Country (2015-2019)
8.2 Brazil Sorafenib Sales and Growth Rate (2015-2019)
8.3 Argentina Sorafenib Sales and Growth Rate (2015-2019)
8.4 Colombia Sorafenib Sales and Growth Rate (2015-2019)
9 Middle East and Africa Sorafenib by Countries
9.1 Middle East and Africa Sorafenib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Sorafenib Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Sorafenib Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Sorafenib Sales and Growth Rate (2015-2019)
9.3 Turkey Sorafenib Sales and Growth Rate (2015-2019)
9.4 Egypt Sorafenib Sales and Growth Rate (2015-2019)
9.5 Nigeria Sorafenib Sales and Growth Rate (2015-2019)
9.6 South Africa Sorafenib Sales and Growth Rate (2015-2019)
10 Global Sorafenib Market Segment by Type
10.1 Global Sorafenib Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Sorafenib Sales and Market Share by Type (2015-2019)
10.1.2 Global Sorafenib Revenue and Market Share by Type (2015-2019)
10.2 Capsule Sales Growth and Price
10.2.1 Global Capsule Sales Growth (2015-2019)
10.2.2 Global Capsule Price (2015-2019)
10.3 Tablet Sales Growth and Price
10.3.1 Global Tablet Sales Growth (2015-2019)
10.3.2 Global Tablet Price (2015-2019)
11 Global Sorafenib Market Segment by Application
11.1 Global Sorafenib Sales Market Share by Application (2015-2019)
11.2 Hospital Pharmacy Sales Growth (2015-2019)
11.3 Retail Pharmacy Sales Growth (2015-2019)
11.4 Online Pharmacy Sales Growth (2015-2019)
12 Sorafenib Market Forecast (2020-2025)
12.1 Global Sorafenib Sales, Revenue and Growth Rate (2020-2025)
12.2 Sorafenib Market Forecast by Regions (2020-2025)
12.2.1 North America Sorafenib Market Forecast (2020-2025)
12.2.2 Europe Sorafenib Market Forecast (2020-2025)
12.2.3 Asia-Pacific Sorafenib Market Forecast (2020-2025)
12.2.4 South America Sorafenib Market Forecast (2020-2025)
12.2.5 Middle East and Africa Sorafenib Market Forecast (2020-2025)
12.3 Sorafenib Market Forecast by Type (2020-2025)
12.3.1 Global Sorafenib Sales Forecast by Type (2020-2025)
12.3.2 Global Sorafenib Market Share Forecast by Type (2020-2025)
12.4 Sorafenib Market Forecast by Application (2020-2025)
12.4.1 Global Sorafenib Sales Forecast by Application (2020-2025)
12.4.2 Global Sorafenib Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
